IMI2_TransBioLine

@IMITransBioLine

Translational Safety Biomarker Pipeline: Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

Vrijeme pridruživanja: travanj 2019.

Tweetovi

Blokirali ste korisnika/cu @IMITransBioLine

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IMITransBioLine

  1. Happy holidays and best wishes for 2020!🎄

    Poništi
  2. 5. srp 2019.
    Poništi
  3. proslijedio/la je Tweet
    28. svi 2019.

    We want more in IMI, so we're creating a pool of patient experts. Want to get involved? Visit our website, check out the info, and sign up for our webinar on 18 June! -->

    The why, who and how of IMI's pool of patient experts
    Poništi
  4. 2. svi 2019.

    TransBioLine Project is funded by the as a public-private partnership, with a budget of 28M€ and will be active through 2024.

    Poništi
  5. The TransBioLine Project is a consortium of 27 partners across pharmaceutical companies, small and medium-sized enterprises, and academic institutions from 10 European countries

    Poništi
  6. . Launches Translational Safety Biomarker Pipeline (TransBioLine) Project. .

    Poništi
  7. TransBioLine project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821283. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA Companies

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·